PTC Therapeutics Inc
NASDAQ:PTCT

Watchlist Manager
PTC Therapeutics Inc Logo
PTC Therapeutics Inc
NASDAQ:PTCT
Watchlist
Price: 43.24 USD -7.47% Market Closed
Market Cap: 3.4B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
-23%
Revenue
Forecast
+12%
Operating Income
Forecast
N/A
Net Income
Forecast
+37%

Wall Street
Price Targets

PTCT Price Targets Summary
PTC Therapeutics Inc

Wall Street analysts forecast PTCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PTCT is 64.55 USD with a low forecast of 42.42 USD and a high forecast of 118.65 USD.

PTCT Lowest Forecast
Wall Street Target
42.42 USD
2% Downside
PTCT Average Forecast
Wall Street Target
64.55 USD
49% Upside
PTCT Highest Forecast
Wall Street Target
118.65 USD
174% Upside
Lowest
Price Target
42.42 USD
2% Downside
Average
Price Target
64.55 USD
49% Upside
Highest
Price Target
118.65 USD
174% Upside
PTC Therapeutics Inc Competitors:
Price Targets
CDNA
CareDx Inc
89% Upside
B
251120
Bio-FD&C Co Ltd
55% Upside
J
600201
Jinyu Bio-Technology Co Ltd
12% Upside
VYGR
Voyager Therapeutics Inc
350% Upside
CDNA
CareDx Inc
89% Upside
B
251120
Bio-FD&C Co Ltd
55% Upside
J
600201
Jinyu Bio-Technology Co Ltd
12% Upside
VYGR
Voyager Therapeutics Inc
350% Upside
S
4599
StemRIM Inc
149% Upside
N
688105
Nanjing Vazyme Biotech Co Ltd
3% Upside
301080
Acrobiosystems Co Ltd
3% Downside
SOBI
Swedish Orphan Biovitrum AB (publ)
48% Upside

Revenue
Forecast

Revenue Estimate
PTC Therapeutics Inc

For the last 8 years the compound annual growth rate for PTC Therapeutics Inc's revenue is 33%. The projected CAGR for the next 3 years is 11%.

33%
Past Growth
11%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
PTC Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
PTC Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-11%
Average Miss
What are analyst estimates?

See Also

Summary
PTCT intrinsic value, competitors valuation, and company profile.
DCF Valuation
PTCT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PTCT stock valuation using valuation multiples.
Wall Street Estimates
PTCT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PTCT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PTCT's stock price target?
Price Target
64.55 USD

According to Wall Street analysts, the average 1-year price target for PTCT is 64.55 USD with a low forecast of 42.42 USD and a high forecast of 118.65 USD.

What is PTC Therapeutics Inc's Revenue forecast?
Projected CAGR
11%

For the last 8 years the compound annual growth rate for PTC Therapeutics Inc's revenue is 33%. The projected CAGR for the next 3 years is 11%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 244,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.